Kidney Transplantation

Slides:



Advertisements
Similar presentations
IMMUNOMODULATORS Dr. Manjunath.
Advertisements

Transplant Immunobiology
HLA TYPING D Middleton MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF THE RUSSELL GROUP.
Introduction to immune system: Immunity: The resistance offered by the host to the harmfull effects of pathogenic microbial infection or any foreign material.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 69 Immunosuppressants.
Transplantation MCB150 Beatty
New Developments in the Management of Kidney Transplant Patients
Immunology and Immunosuppression December 8, 2009.
The Major Histocompatibility Complex And Antigen Presentation
Renal (Kidney) Transplantation Kidney Transplant Inserting a kidney of another live or dead person into a person. The donor kidney is typically placed.
IMMUNOLOGY OF TRANSPLANTATION Lecture /2014 Jan Żeromski.
Major Histocompatibility Complex and Transplantation
MHC and AG Presentation1 MHC and Antigen Presentation Chapters 6 & 7 Self-Test Questions: Chap 6 A: 1 – 5, 8 Note: for A-5 know MHC I - III B – D: all.
Major Histocompatibility Complex and Transplantation Major histocompatibility complex (MHC) proteins were discovered for the first time with the advent.
Immunology of transplantation. Types of transplantation Autotransplantation –within one organism Allotransplantation- between one species Xenotransplantation-
Cell Mediated Immunity
Immunology 2 nd Med 2009 Some revision points Con Feighery.
MAJOR HISTOCOMPATIBILITY COMPLEX
Transplantation Immunology Unit College of Medicine
Antineoplastics 1 February :08 AM.
Transplantation Prof. Zahid Shakoor College of Medicine King Saud University.
Immunopharmacology 8 March :42 AM.
IMMUNOSUPPRESSANT THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
UNIVERSITY OF KERBALA COLLEGE OF MEDICINE Department of Pharmacology Immunosuppressant Drugs Dr. Haidar Al-Muthaffar MBChB, MSc, PhD Head of Pharmacology.
Kidney Transplantation. Best treatment of chronic renal failure.
History of Kidney Transplantation
Immunotherapy. Definition The approach to balance or intervene the immunologic function in order to fight against the disease by the principle of immunology.
Immunosuppressives & chemo tutoring
Major Histocompatibility Complex (MHC)
Transplant Overview By Alaina Darby.
Chapter 7. 주조직적합성 복합체 1. 주조직적합성 복합체 (MHC)의 발견 2. MHC 분자의 구조
MAJOR HISTOCOMPATIBILITY COMPLEX
Major Histocompatibility Complex
IMMUNOSUPPRESSANT DRUGS
Adaptive immunity antigen recognition Y Y Y Y Y Y Y Y Y invading
Transplantation: Mechanisms of Tacrolimus
Transplantation Immunology Unit College of Medicine
Cell Mediated Immunity
Immuno-pharmacology 4th Class Dr Sherzad Kh. RASHID
Immuno-pharmacology 4th Class Dr Sherzad Kh. RASHID
Immunological aspects of transplantation and pregnancy
Transplantation David Straus, Ph.D. Objectives
Tissue and Organ Transplantation
By: Jubair Aziz, Jing Nan Qiao, Bita Janzadeh
Transplantation Immunology Unit College of Medicine
This diagram outlines the key mechanisms by which calcineurin (Cn) inhibitors and mammalian target of rapamycin (mTOR) inhibitors inhibit T-cell activation.
Transplantation Pathology
The Major Histocompatibility Complex (MHC)
Adaptive Immune Response (Cell Mediated Immunity)
Renal Transplantation
Paediatric Renal Transplantation
Immunological aspect of transplantation
Major Histocompatibility complex OR
Major Histocompatibility complex OR
Major Histocompatibility Complex
SOLID ORGAN TRANSPLANTATION
Updates in Transplant Medication and Technology
Major Histocompatibility complex OR
Immunomodulators Pharmacology IV (PHL 425)
Chapter 8 Major Histocompatibility Complex Dr. Capers
SOLID ORGAN TRANSPLANTATION
بنام خداي زيبائيها.
Transplant Immunology
The major histocompatibility complex (MHC) and MHC molecules
The Major Histocompatibility Complex (MHC)
Kidney Transplant Dr. Basu.
Multiple Choice Test Tips
Cell Mediated Immunity
Heterozygous for all alleles in MHC II
Human Leukocyte Antigen (HLA)
Presentation transcript:

Kidney Transplantation

Best treatment of chronic renal failure

HEMODIALYSIS

PERITONEAL DIALYSIS

Renal transplantation needs donor kidney

Organ Source Cadaver Living donor

Yalnız kalp atacak

HLA TYPING HLA ANTIGENS A B C DR LOCUS HLA A21,A24,B7,B9,DR22

MAJOR HISTOCOMPATABILITY COMPLEX Class I - present on almost all nucleated cells (interesting exceptions include sperm and the cells of the trophoblast). Class II- present on Antigen Presenting Cells (macrophages, B cells, and dendritic cells). Class III- are not surface molecules, but instead are various proteins typically which have some immunological role (C2,C4,Tumor necrosis factor alpha and beta, various HSPs) Human HLA region [Highly Simplified version !] ---DP--DQ--DR------------C4--C2--Bf---------------B--C--A--- Protein Products: DPa and DPb Complement HLA-B (a) DQa and DQb TNF a & b HLA-C (a) DRa and DRb HSP proteins HLA-A (a)

Human MHC genes are highly polymorphic

HLA TYPING A-MATCH…FULL B-MATCH..ONE ANTIGEN DIFFERENT C-MATCH..TWO ANTIGENS DIFFERENT …..SO ON THE MORE CLOSER TO A-MATCH, THE MORE SUCCESSFULL KIDNEY TRANSPLANTATION

RECIPIENT SHOULD NOT HAVE ANY INFECTION

IMMUNUSUPRESSION

The TcR-CD3 complex on helper (CD4+) or cytotoxic/suppressor (CD8+) T cells

IMMUNOSUPRESSIVE AGENTS T-CELL BLOCKERS GLUCOCORTICOIDS SITOTOXIC AGENTS MONOCLONAL ANTIBODIES

T-CELL BOCKERS CYCLOSPORINE-A TACROLIMUS SIROLIMUS CYCLOSPORINE AND TACROLIMUS ARE SELECTIVE CALCINEURIN INHIBITORS INHIBITION OF Th INDUCTION WHICH IS ACTIVATED BY IL-2

NFAT :Nuclear factor of activated T-cells FKBP: FK Binding protein

TOXIC EFFECTS OF TACROLIMUS AND CYCLOSPORINE . NEPHROTOXICITY (C>T) . NEUROTOXICITY (T>C) . GASTROINTESTINAL PROBLEMS(T) . HYPERTENSION(C>>T) . HYPERKALEMIA(T) . HPERGLICEMIA AND DIABETES(T>C) . INFECTION AND MALIGN TUMORS(BOTH)

SIROLIMUS(RAPAMYCINE) Blockage of mTOR kinase Side Effects: Hyperlipidemia Anemia Leucopenia, trombositopenia Fever GI effects, Hypo and hyperkalemia

IMMUNOSUPRESSIVE EFFECTS OF GLUCOCORTICOIDS -Inhibition of release of cytokines in T-Cells -Inhibition of antibody production in B-Cells -Inhibition of macrophages,monocytes,PMNL’s -Blockage of complement system

SIDE EFFECS OF STEROIDS -Cushing Syndrome -Glucose intolerance -Infections -Osteoporosis -Muscle weakness

Antineoplastic drugs as immunosupressive agents -Mycophenolat Mofetil (Inhibition of IMP dehydrogenase) -Azathioprine (Inhibition of nucleotid synthesis) -Cyclophosphamide (Alkylating agents ) -Methotrexate (Inhibitor of dihydrofolate reductase)

BIOLOGIC IMMUNOSUPPRESSION -Antilymphosite globulines(Polyclonal antibodies) (Atgam, timoglobulin) -Anti-CD3 monoclonal antibodies (OKT3, muromonab-CD3) all -mab, -imab and -umab suffixes -Anti-Tac, Anti-CD25 monoclonal antibodies (Basiliximab, daclizumab) Anti-CD25 Monoclonal Antibodies (Basiliximab and Daclizumab) Anti-CD52 Monoclonal Antibody Alemtuzumab (Campath-1h) Anti-CD20 (Rituximab) Monoclonal Antibodies to Adhesion Molecules anti–LFA-1 mAb (efalizumab) anti-CD4 mAb (priliximab)

PROF. DR. MEHMET A. HABERAL

16 DECEMBER 2006

Kidney transplantation: Meryem (28 years old) Kidney transplantation: 7 June 1997 Marriage : 2001 Baby : 2002

THE END